M, D., K, W., NWCJ, v. d. D., K, R., B, G., M, S., . . . P, S. (2018). Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.
Citação norma ChicagoM, Dimopoulos, et al. Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial. 2018.
Citação norma MLAM, Dimopoulos, et al. Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial. 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.